1. Home
  2. APLT vs LESL Comparison

APLT vs LESL Comparison

Compare APLT & LESL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • LESL
  • Stock Information
  • Founded
  • APLT 2016
  • LESL 1963
  • Country
  • APLT United States
  • LESL United States
  • Employees
  • APLT N/A
  • LESL N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • LESL Diversified Commercial Services
  • Sector
  • APLT Health Care
  • LESL Miscellaneous
  • Exchange
  • APLT Nasdaq
  • LESL Nasdaq
  • Market Cap
  • APLT 69.0M
  • LESL 66.9M
  • IPO Year
  • APLT 2019
  • LESL 2020
  • Fundamental
  • Price
  • APLT $0.51
  • LESL $0.32
  • Analyst Decision
  • APLT Buy
  • LESL Hold
  • Analyst Count
  • APLT 6
  • LESL 9
  • Target Price
  • APLT $6.10
  • LESL $1.66
  • AVG Volume (30 Days)
  • APLT 893.4K
  • LESL 4.3M
  • Earning Date
  • APLT 08-13-2025
  • LESL 08-06-2025
  • Dividend Yield
  • APLT N/A
  • LESL N/A
  • EPS Growth
  • APLT N/A
  • LESL N/A
  • EPS
  • APLT N/A
  • LESL N/A
  • Revenue
  • APLT $121,000.00
  • LESL $1,250,568,000.00
  • Revenue This Year
  • APLT $415.60
  • LESL N/A
  • Revenue Next Year
  • APLT $1,323.96
  • LESL $1.27
  • P/E Ratio
  • APLT N/A
  • LESL N/A
  • Revenue Growth
  • APLT N/A
  • LESL N/A
  • 52 Week Low
  • APLT $0.30
  • LESL $0.27
  • 52 Week High
  • APLT $10.62
  • LESL $3.63
  • Technical
  • Relative Strength Index (RSI)
  • APLT 61.88
  • LESL 42.69
  • Support Level
  • APLT $0.47
  • LESL $0.29
  • Resistance Level
  • APLT $0.53
  • LESL $0.37
  • Average True Range (ATR)
  • APLT 0.03
  • LESL 0.04
  • MACD
  • APLT 0.00
  • LESL 0.00
  • Stochastic Oscillator
  • APLT 83.33
  • LESL 46.83

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About LESL Leslie's Inc.

Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.

Share on Social Networks: